DOI: 10.1055/s-00000021

Gesundheitsökonomie & Qualitätsmanagement

References

Ruof J, Dintios CM, Schwartz F.
Early benefit assessment (EBA) in Germany: differences between pharmaceutical companies’ claims and IQWIG benefit assessments. Abstract PHP 148; ISPOR 15th Annual European Congress, 3–7 November 2012, Berlin, Germany.

Value Health 2012;
15 (07) A315

Download Bibliographical Data

Search in: